Despite the positive long-term outlook for healthcare companies, short-term challenges like COVID inventory destocking have caused the industry to underperform recently. Three healthcare stocks to avoid include West Pharmaceutical Services (WST), with only 1.6% annual revenue growth and a high forward P/E ratio of 37.3x. Azenta (AZTA) saw sales decline by 7.2% annually over the last five years, leading to a forward P/E ratio of 39.9x. Royalty Pharma (RPRX) has faced declining sales and subscale operations, trading at 7.3x forward P/E. Check out our free research reports to understand why these stocks may not be the best choices for your portfolio. For better investment opportunities, explore our Top 6 Stocks list, which includes high-quality stocks that have outperformed the market over the last five years. Discover potential winners with StockStory today.

Read more at StockStory: 3 Healthcare Stocks We Keep Off Our Radar